Forensic Phenotyping
The Future of Identification


Cloverleaf Group is a privately held, alternative investment group which is primarily focused on venture capital and private equity investment opportunities in the healthcare, life sciences and breakthrough technologies.

With a deep understanding of complex, structured and cross-border situations, Cloverleaf is actively involved with opportunities that require a significant commitment of human as well as financial capital, such as early stage company incubations through to distressed or turnaround situations.

As our investment scope has historically not been limited by a defined investment horizon or specific fund mandate, Cloverleaf has developed into a nimble and opportunistic investor with expertise on non-typical opportunities at any stage of a company’s life cycle and in any part of its capital structure.

Cloverleaf's current portfolio includes:
Website Builder